HARMONIC EXCITATION THERAPY AND ANTI-TUMOR AGENT

An anti-tumor agent is provided to a patient to increase a susceptibility of a tumor within the patient to harmonic excitation. Ultrasonic transducers of a wearable are driven to direct a therapeutic ultrasound signal into tissue of the patient. The therapeutic ultrasound signal has a resonant ultra...

Full description

Saved in:
Bibliographic Details
Main Authors TASKIN, Ulas, ACHROL, Achal Singh, BAWIEC, Christopher R, ORNELLAS, Sarah Barreto, KONECKY, Soren, HARTL, Brad A
Format Patent
LanguageEnglish
French
Published 21.09.2023
Subjects
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:An anti-tumor agent is provided to a patient to increase a susceptibility of a tumor within the patient to harmonic excitation. Ultrasonic transducers of a wearable are driven to direct a therapeutic ultrasound signal into tissue of the patient. The therapeutic ultrasound signal has a resonant ultrasound frequency to harmonically excite and damage the tumor while the anti-tumor agent has increased the susceptibility of the tumor to the harmonic excitation of the therapeutic ultrasound signal. Un agent antitumoral est administré à un patient pour augmenter une sensibilité d'une tumeur à l'intérieur du patient à une excitation harmonique. Des transducteurs ultrasonores d'un dispositif portable sont actionnés pour diriger un signal ultrasonore thérapeutique dans un tissu du patient. Le signal ultrasonore thérapeutique a une fréquence ultrasonore résonante pour exciter de manière harmonique et endommager la tumeur tandis que l'agent antitumoral a augmenté la sensibilité de la tumeur à l'excitation harmonique du signal ultrasonore thérapeutique.
Bibliography:Application Number: WO2023US64663